Suppr超能文献

减少全身肝素化和肝素涂层管路对抗凝血酶III的节约作用。

The antithrombin III-saving effect of reduced systemic heparinization and heparin-coated circuits.

作者信息

Ranucci Marco, Cazzaniga Anna, Soro Giorgio, Isgrò Giuseppe, Frigiola Alessandro, Menicanti Lorenzo

机构信息

Departments of Cardiothoracic Anesthesia and Cardiac Surgery, Cardiovascular Center E. Malan-University of Milan, Istituto Policlinico S.Donato, Milan, Italy.

出版信息

J Cardiothorac Vasc Anesth. 2002 Jun;16(3):316-20. doi: 10.1053/jcan.2002.124140.

Abstract

OBJECTIVE

To investigate the perioperative changes of antithrombin III (AT-III) activity using reduced systemic heparinization and the possible role of AT-III in determining a better postoperative outcome.

DESIGN

Prospective randomized study.

SETTING

University hospital.

PARTICIPANTS

Patients undergoing elective coronary revascularization with cardiopulmonary bypass (n = 90).

INTERVENTIONS

Of patients, 30 were treated with heparin-coated circuits and reduced systemic heparinization; 30, with heparin-coated circuits and full systemic heparinization; 30, with conventional circuits and full systemic heparinization.

MEASUREMENTS AND MAIN RESULTS

Heparin-coated circuits with full systemic heparinization did not exert any effect on coagulation parameters. Low systemic heparinization resulted in a significantly (p < 0.01) higher hematocrit value on arrival in the intensive care unit and in significantly higher values of AT-III activity during cardiopulmonary bypass (66 +/- 12% v 57.4 +/- 13% and 59.1 +/- 12% in the full systemic heparinization groups; p < 0.05), on arrival in the intensive care unit (69.7 +/- 13% v 60.7 +/- 13% and 60.8 +/- 11% in the full systemic heparinization groups; p < 0.01), and on the first postoperative day (81.3 +/- 15% v 67.4 +/- 13% and 70.2 +/- 12% in the full systemic heparinization groups; p < 0.01). No differences were observed in the clinical outcome.

CONCLUSION

Reducing systemic heparinization determines an AT-III-saving effect that could be responsible for the decrease in thromboembolic complications already observed by other authors. It induces higher hematocrit levels immediately after the operation, probably reducing the unmeasurable intraoperative blood loss.

摘要

目的

探讨采用减少全身肝素化时抗凝血酶III(AT-III)活性的围手术期变化以及AT-III在确定更好术后结局中的可能作用。

设计

前瞻性随机研究。

地点

大学医院。

参与者

接受择期冠状动脉血运重建并使用体外循环的患者(n = 90)。

干预措施

患者中,30例采用肝素涂层回路并减少全身肝素化治疗;30例采用肝素涂层回路并进行充分全身肝素化;30例采用传统回路并进行充分全身肝素化。

测量指标及主要结果

采用充分全身肝素化的肝素涂层回路对凝血参数无任何影响。低全身肝素化导致在重症监护病房入院时血细胞比容值显著更高(p < 0.01),并且在体外循环期间AT-III活性值显著更高(充分全身肝素化组分别为66 ± 12% 对57.4 ± 13%和59.1 ± 12%;p < 0.05),在重症监护病房入院时(充分全身肝素化组分别为69.7 ± 13% 对60.7 ± 13%和60.8 ± 11%;p < 0.01),以及在术后第一天(充分全身肝素化组分别为81.3 ± 15% 对67.4 ± 13%和70.2 ± 12%;p < 0.01)。临床结局未观察到差异。

结论

减少全身肝素化可产生节省AT-III的效应,这可能是其他作者已观察到的血栓栓塞并发症减少的原因。它在术后立即诱导更高的血细胞比容水平,可能减少了术中不可测量的失血。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验